Garuda Therapeutics

company

About

Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat severe and life-threatening diseases.

  • 51 - 100

Details

Last Funding Type
Series A
Last Funding Money Raised
$72M
Industries
Biotechnology,Life Science,Therapeutics
Founded date
Jan 1, 2021
Number Of Employee
51 - 100
Operating Status
Active

Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$72M
Garuda Therapeutics has raised a total of $72M in funding over 2 rounds. Their latest funding was raised on Sep 23, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 23, 2021 Series A $72M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Garuda Therapeutics is funded by 1 investors. Resilience are the most recent investors.
Investor Name Lead Investor Funding Round
Resilience Series A